AR127403A1 - Nuevas sales de trimetazidina - Google Patents
Nuevas sales de trimetazidinaInfo
- Publication number
- AR127403A1 AR127403A1 ARP220102840A ARP220102840A AR127403A1 AR 127403 A1 AR127403 A1 AR 127403A1 AR P220102840 A ARP220102840 A AR P220102840A AR P220102840 A ARP220102840 A AR P220102840A AR 127403 A1 AR127403 A1 AR 127403A1
- Authority
- AR
- Argentina
- Prior art keywords
- trimetazidine
- acid
- salt
- salts
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306465 | 2021-10-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR127403A1 true AR127403A1 (es) | 2024-01-17 |
Family
ID=78592764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP220102840A AR127403A1 (es) | 2021-10-20 | 2022-10-19 | Nuevas sales de trimetazidina |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20250250245A1 (enExample) |
| EP (1) | EP4419510B1 (enExample) |
| JP (1) | JP2024539090A (enExample) |
| KR (1) | KR20240093576A (enExample) |
| CN (1) | CN118076591A (enExample) |
| AR (1) | AR127403A1 (enExample) |
| AU (1) | AU2022369026A1 (enExample) |
| CR (1) | CR20240157A (enExample) |
| DK (1) | DK4419510T3 (enExample) |
| ES (1) | ES3057370T3 (enExample) |
| HR (1) | HRP20251413T1 (enExample) |
| IL (1) | IL311916A (enExample) |
| LT (1) | LT4419510T (enExample) |
| MA (1) | MA66951B1 (enExample) |
| MX (1) | MX2024004714A (enExample) |
| PL (1) | PL4419510T3 (enExample) |
| PT (1) | PT4419510T (enExample) |
| RS (1) | RS67449B1 (enExample) |
| SI (1) | SI4419510T1 (enExample) |
| WO (1) | WO2023066971A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025106477A1 (en) * | 2023-11-14 | 2025-05-22 | Samsara Therapeutics Inc. | Novel autophagy inducing compounds and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104138376A (zh) * | 2013-05-06 | 2014-11-12 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 一种提高缺氧耐受力的缓释剂 |
| FR3027803B1 (fr) | 2014-11-05 | 2018-02-09 | Les Laboratoires Servier | Composition pharmaceutique comprenant un betabloquant et un inhibiteur de l'enzyme de conversion |
| CN105287564A (zh) * | 2015-09-06 | 2016-02-03 | 余祖江 | 一种防治肝病的西药复合物及其用途 |
| CN110183398B (zh) | 2019-05-14 | 2021-06-29 | 中南民族大学 | 一种曲美他嗪草酸盐及其制备方法和应用 |
| CN110105307B (zh) | 2019-05-14 | 2021-06-01 | 中南民族大学 | 一种曲美他嗪草酸盐及其制备方法和应用 |
| CN110054599B (zh) * | 2019-05-14 | 2021-05-07 | 中南民族大学 | 一种曲美他嗪草酸盐及其制备方法和应用 |
| CN112043691A (zh) * | 2019-06-06 | 2020-12-08 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 一种药物组合物及其用途 |
-
2022
- 2022-10-19 RS RS20251183A patent/RS67449B1/sr unknown
- 2022-10-19 MX MX2024004714A patent/MX2024004714A/es unknown
- 2022-10-19 CR CR20240157A patent/CR20240157A/es unknown
- 2022-10-19 LT LTEPPCT/EP2022/079054T patent/LT4419510T/lt unknown
- 2022-10-19 US US18/702,363 patent/US20250250245A1/en active Pending
- 2022-10-19 AR ARP220102840A patent/AR127403A1/es unknown
- 2022-10-19 EP EP22808665.8A patent/EP4419510B1/en active Active
- 2022-10-19 IL IL311916A patent/IL311916A/en unknown
- 2022-10-19 PL PL22808665.8T patent/PL4419510T3/pl unknown
- 2022-10-19 AU AU2022369026A patent/AU2022369026A1/en active Pending
- 2022-10-19 ES ES22808665T patent/ES3057370T3/es active Active
- 2022-10-19 SI SI202230206T patent/SI4419510T1/sl unknown
- 2022-10-19 PT PT228086658T patent/PT4419510T/pt unknown
- 2022-10-19 DK DK22808665.8T patent/DK4419510T3/da active
- 2022-10-19 HR HRP20251413TT patent/HRP20251413T1/hr unknown
- 2022-10-19 WO PCT/EP2022/079054 patent/WO2023066971A1/en not_active Ceased
- 2022-10-19 MA MA66951A patent/MA66951B1/fr unknown
- 2022-10-19 JP JP2024523404A patent/JP2024539090A/ja active Pending
- 2022-10-19 CN CN202280068113.8A patent/CN118076591A/zh active Pending
- 2022-10-19 KR KR1020247015968A patent/KR20240093576A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL311916A (en) | 2024-06-01 |
| CR20240157A (es) | 2024-05-22 |
| EP4419510B1 (en) | 2025-10-08 |
| ES3057370T3 (en) | 2026-03-02 |
| WO2023066971A1 (en) | 2023-04-27 |
| JP2024539090A (ja) | 2024-10-28 |
| LT4419510T (lt) | 2025-12-29 |
| CN118076591A (zh) | 2024-05-24 |
| CA3234743A1 (en) | 2023-04-27 |
| US20250250245A1 (en) | 2025-08-07 |
| RS67449B1 (sr) | 2025-12-31 |
| KR20240093576A (ko) | 2024-06-24 |
| EP4419510A1 (en) | 2024-08-28 |
| HRP20251413T1 (hr) | 2025-12-19 |
| MA66951B1 (fr) | 2025-12-31 |
| AU2022369026A1 (en) | 2024-05-02 |
| PT4419510T (pt) | 2026-01-02 |
| SI4419510T1 (sl) | 2026-01-30 |
| MX2024004714A (es) | 2024-05-10 |
| DK4419510T3 (da) | 2025-11-17 |
| PL4419510T3 (pl) | 2026-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY39425A (es) | Un proceso para la síntesis de compuestos antranílicos de ácido/amida e intermedios de los mismos | |
| AR067762A1 (es) | Proceso para preparar 5-fluoro-1h-pirazolo (3,4-b) piridin-3-amina y derivados de la misma | |
| PE20191784A1 (es) | Compuestos inhibidores de vmat2, composiciones y metodos relativos a los mismos | |
| AR077526A1 (es) | Metodo para la sintesis de (1s,2r)- milnacipran | |
| CL2023002722A1 (es) | Derivados de morfolinas sustituidas y usos de estos | |
| CY1108816T1 (el) | Παραγωγα ν-(1η-ινδολυλο)-iη-ινδολο-καρβοξαμιδιων, η προετοιμασια αυτων και η εφαρμογη τους στη θεραπευτικη | |
| PE20190964A1 (es) | Inhibidores de dopamina-b-hidroxilasa penetrantes de la barrera hematoencefalica | |
| AR123593A1 (es) | Un proceso para la síntesis de compuestos antranílicos de ácido / amida e intermedios de los mismos | |
| CO2024013702A2 (es) | Derivados de pirido-[3,4-d]piridazina amina útiles como derivados de nlrp3 | |
| PE20090548A1 (es) | Compuestos aza-biciclohexano como inhibidores de trombina | |
| AR057033A1 (es) | Tigeciclina y metodos para preparar 9-nitrominociclina | |
| UY39801A (es) | Un proceso novedoso para la preparación de diamidas antranílicas | |
| HN2001000110A (es) | 5-cloro -3-(metansulfonilfelino)-6-metil-[2.3] bipiridinilo en forma cristalina pura y proceso para la sintesis | |
| ECSP22091930A (es) | Procesos para preparar un inhibidor de jak1 | |
| CO2023006912A2 (es) | Nuevos derivados de indazol acetileno | |
| DOP2025000064A (es) | Proceso para la preparación de un agente de contraste de gadolinio | |
| CO2025013218A2 (es) | Derivados de morfolinas sustituidas y usos de estas | |
| AR054374A1 (es) | Procedimientos utiles para sintesis de compuestos farmaceuticos en especial inhibidores de renina (aliskiren), intermediarios y compuestos farmaceuticos | |
| AR084100A1 (es) | Procesos para la preparacion de enaminas | |
| Ishimoto et al. | A practical chromatography-free synthesis of a 5, 6-dihydroimidazolo [1, 5-f] pteridine derivative as a polo-like kinase-1 inhibitor | |
| PY2510648A (es) | Método para producir compuesto de 3-hidroxibifenilo y derivado del mismo. | |
| AR123899A1 (es) | Métodos para elaborar derivados de ácido nicotínico | |
| AR084098A1 (es) | Procesos para la preparacion de enaminas | |
| ES2309416T3 (es) | Procedimiento estereoselectivo para la preparacion de clopidogrel. | |
| PY2427387A (es) | Método para producir compuesto de 3-hidroxibifenilo y derivado del mismo |